Comparative effectiveness and integrated safety of goserelin sustained-release microspheres versus implants in prostate cancer: a patient-based real-world study and systematic review with meta-analysis - Top-Institutions - MDSpire

Comparative effectiveness and integrated safety of goserelin sustained-release microspheres versus implants in prostate cancer: a patient-based real-world study and systematic review with meta-analysis

  • By

  • Jie Zhao

  • Qiang Zhao

  • Xiaohong Liu

  • Kun Hou

  • Yuan Chen

  • Hua Lan

  • Yaodong Ping

  • June 17, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Peking University Cancer Hospital Inner Mongolia Hospital
    Peking University Cancer Hospital Inner Mongolia Hospital

    Hohhot, Inner Mongolia

    Key Differentiators

    • Urology

  • #2

    MRC Clinical Trials Unit at University College London
    MRC Clinical Trials Unit at University College London

    London, England

    Key Differentiators

    • Clinical Trials

  • #3

    Anning First People's Hospital Affiliated to Kunming University of Science and Technology
    Anning First People's Hospital Affiliated to Kunming University of Science and Technology

    Anning, Yunnan

    Key Differentiators

    • Urology

Original Source(s)

Comparative effectiveness and integrated safety of goserelin sustained-release microspheres versus implants in prostate cancer: a patient-based real-world study and systematic review with meta-analysis

  • by Jie Zhao, Qiang Zhao, Xiaohong Liu, Kun Hou, Yuan Chen, Hua Lan, Yaodong Ping

  • June 17, 2026

Related Content

Case Report: Neoadjuvant chemoimmunotherapy achieving pathological complete response in two cases of stage III EGFR-mutant NSCLC with high PD-L1 expression

PTHrP-associated hypercalcemia in gynecologic malignancies: a scoping review

Multimodal fusion of EHR and ECG based on deep learning for predicting new-onset coronary heart disease in cancer patients